STOCK *LOL*

anonymous

Guest
Down 22% today, almost to under $2 a share after that stellar Q2 report. I guess investors realize that the CEO is lying and hiding/fudging numbers and the volume of units in the door doesn't hold a candle to Natera and Ariosa. Titanic, iceberg dead ahead. Oh wait, we already hit it!
 






Down 22% today, almost to under $2 a share after that stellar Q2 report. I guess investors realize that the CEO is lying and hiding/fudging numbers and the volume of units in the door doesn't hold a candle to Natera and Ariosa. Titanic, iceberg dead ahead. Oh wait, we already hit it!

Couldn't be more accurate
 






























How much shareholder value has this inept management team lost just in this year? Unbelievable they are all still in place pulling down $500K base + 1,000,000 bonuses.
 












Of course Genome will not reverse the slide. The problem is not the science, it is the inept scatterbrained leadership. Lack of organization, lack of communication and zero clarity makes for horrendous results. People are working their butts off in the field.. and not getting any recognition. Morale is at an all time low. This company is a mess.
 






Maternity genome will only meet a very small segment of the populations needs and I don't see how it will turn us around. The data just isn't strong enough to replace amnio and not appropriate to use vs MT21. It is depressing here and condescending to out level if intelligence that leadership is trying to make us believe otherwise.